Advancing Breakthroughs in Brain Health
Advancing CNS research with smarter clinical trials
She felt like the weight of the trial was
on her shoulders. Then she found Rho.
The Neural Network Nexus:
Untangling the Complexity of CNS Trials
Every breakthrough starts with a question: How can we push science forward?
Neurological and psychiatric disorders don’t just affect individuals—they impact families, caregivers, and entire communities. Behind every study is a person searching for relief, for progress, for a future that looks different from today. At Rho, we don’t just run trials; we invest in the human stories behind them. We bring deep expertise in central nervous system (CNS) research and a commitment to smarter, more compassionate clinical trials that make a real difference.
Why Rho?
Why Rho?
Experts who care
Thoughtful study design
Innovative data insights
Patient-first approach
Spotlight: Advancing Neurology and Psychiatry Research
In the past five years, we’ve supported more than 90 neurology and psychiatry studies across 840+ sites, including work in Parkinson’s, Alzheimer’s, MDD, ADHD, and substance use disorders. Our teams have guided programs from first-in-human to regulatory submission, including in rare and complex conditions.
These trials aren’t easy. We’ve helped launch more than 440 neurology sites and 400 psychiatry sites, enrolling over 6,500 participants—all while keeping timelines and expectations aligned.
But what matters most is the people behind those numbers. We collaborate closely with groups like the Michael J. Fox Foundation, Parkinson’s Foundation, and Davis Phinney Foundation to stay grounded in what matters most: research that’s not just scientifically sound, but truly centered on people.
Spotlight: Advancing Neurology and Psychiatry Research
In the past five years, we’ve supported more than 90 neurology and psychiatry studies across 840+ sites, including work in Parkinson’s, Alzheimer’s, MDD, ADHD, and substance use disorders. Our teams have guided programs from first-in-human to regulatory submission, including in rare and complex conditions.
These trials aren’t easy. We’ve helped launch more than 440 neurology sites and 400 psychiatry sites, enrolling over 6,500 participants—all while keeping timelines and expectations aligned.
But what matters most is the people behind those numbers. We collaborate closely with groups like the Michael J. Fox Foundation, Parkinson’s Foundation, and Davis Phinney Foundation to stay grounded in what matters most: research that’s not just scientifically sound, but truly centered on people.
Neurology and Psychiatry FAQ
What neurological and psychiatric disorders does Rho specialize in?
Rho has extensive experience in clinical trials for movement disorders, neurodegenerative diseases, psychiatric conditions, and rare CNS diseases. Our expertise spans Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, substance use disorders, and more.
What makes CNS clinical trials uniquely challenging?
Neurology and psychiatry trials often require specialized outcome measures, biomarker validation, and patient recruitment strategies for complex conditions. Rho’s deep expertise in CNS research helps sponsors navigate these complexities successfully.
How does Rho support patient recruitment for CNS trials?
Recruiting for neurological and psychiatric trials can be difficult due to strict inclusion criteria and long trial durations. Rho leverages targeted site selection, patient engagement strategies, and digital recruitment tools to enhance enrollment.
Does Rho offer expertise in rare CNS disease research?
Comprehensive support for neurology
and psychiatry trials
Neurodegenerative diseases
Movement disorders
Psychiatric and mood disorders
Rare neurological conditions
CNS biomarkers and imaging
Meet the
team
who make
it happen
Related insights & resources
Ready to change lives together?
Behind every trial is a person waiting for progress. Let’s move science forward with purpose and heart.
